Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleksi Tornio

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
American Journal of Preventive Cardiology|July 29, 2024
Ezetimibe use and mortality after myocardial infarction: A nationwide cohort studyVille Kytö, Aleksi Tornio
Advances in Pharmacology (San Diego, Calif.)|May 27, 2018
Cytochrome P450 in Pharmacogenetics: An UpdateAleksi Tornio, Janne T Backman
Atherosclerosis|July 8, 2022
Early statin use and cardiovascular outcomes after myocardial infarction: A population-based case-control studyVille Kytö, Antti Saraste, Aleksi Tornio
European Heart Journal. Cardiovascular Pharmacotherapy|November 17, 2022
Initial statin dose after myocardial infarction and long-term cardiovascular outcomesVille Kytö, Päivi Rautava, Aleksi Tornio
Basic & Clinical Pharmacology & Toxicology|April 3, 2016
High Frequency of CYP2D6 Ultrarapid Metabolizer Genotype in the Finnish PopulationPaavo Pietarinen, Aleksi Tornio, Mikko Niemi
Basic & Clinical Pharmacology & Toxicology|April 14, 2022
Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillationVille Kytö, Antti Saraste, Päivi Rautava, et al.
European Journal of Clinical Pharmacology|July 13, 2006
The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopicloneAleksi Tornio, Pertti J Neuvonen, Janne T Backman
Basic & Clinical Pharmacology & Toxicology|August 19, 2021
Translational aspects of cytochrome P450-mediated drug-drug interactions: A case study with clopidogrelAleksi Tornio, Anne M Filppula, Janne T Backman
Maturitas|June 1, 2025
Female sexual dysfunction as an adverse effect of drugs: a narrative reviewMikael O W Piha, Katja Kero, Aleksi Tornio
Basic & Clinical Pharmacology & Toxicology|July 3, 2026
Using Pharmacovigilance Data for Signal Detection of Drug Interactions for RosuvastatinRonja Levomäki, Päivi Hirvensalo, Aleksi Tornio, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
American Journal of Preventive Cardiology|July 29, 2024
Ezetimibe use and mortality after myocardial infarction: A nationwide cohort studyVille Kytö, Aleksi Tornio
Advances in Pharmacology (San Diego, Calif.)|May 27, 2018
Cytochrome P450 in Pharmacogenetics: An UpdateAleksi Tornio, Janne T Backman
Atherosclerosis|July 8, 2022
Early statin use and cardiovascular outcomes after myocardial infarction: A population-based case-control studyVille Kytö, Antti Saraste, Aleksi Tornio
European Heart Journal. Cardiovascular Pharmacotherapy|November 17, 2022
Initial statin dose after myocardial infarction and long-term cardiovascular outcomesVille Kytö, Päivi Rautava, Aleksi Tornio
Basic & Clinical Pharmacology & Toxicology|April 3, 2016
High Frequency of CYP2D6 Ultrarapid Metabolizer Genotype in the Finnish PopulationPaavo Pietarinen, Aleksi Tornio, Mikko Niemi
Basic & Clinical Pharmacology & Toxicology|April 14, 2022
Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillationVille Kytö, Antti Saraste, Päivi Rautava, et al.
European Journal of Clinical Pharmacology|July 13, 2006
The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopicloneAleksi Tornio, Pertti J Neuvonen, Janne T Backman
Basic & Clinical Pharmacology & Toxicology|August 19, 2021
Translational aspects of cytochrome P450-mediated drug-drug interactions: A case study with clopidogrelAleksi Tornio, Anne M Filppula, Janne T Backman
Maturitas|June 1, 2025
Female sexual dysfunction as an adverse effect of drugs: a narrative reviewMikael O W Piha, Katja Kero, Aleksi Tornio
Basic & Clinical Pharmacology & Toxicology|July 3, 2026
Using Pharmacovigilance Data for Signal Detection of Drug Interactions for RosuvastatinRonja Levomäki, Päivi Hirvensalo, Aleksi Tornio, et al.
Pageof 7